This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Condition: Urinary Bladder Overactive · Urinary Bladder Diseases\Urologic Diseases · Overactive Bladder · Sponsor: Astellas Pharma Europe B.V.
About this study
The purpose of this study was to examine how well two medicines (solifenacin succinate and mirabegron) combined work compared to each medicine alone in the treatment of bladder problems.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (435)
| Site US10049 Coastal Clinical Research, Inc. | Mobile, Alabama, United States | — |
| Site US10112 TFI, LLC | Mobile, Alabama, United States | — |
| Site US10104 Clinical Research Advantage, Inc. | Chandler, Arizona, United States | — |
| Site US10021 Beach Clinical Studies | Phoenix, Arizona, United States | — |
| Site US10122 Orange County Research Institute | Anaheim, California, United States | — |
| Site US10098 Skyline Research | Cerritos, California, United States | — |
| Site US10539 Citrus Valley Medical Research | Glendora, California, United States | — |
| Site US10082 American Clinical Trials | Hawaiian Gardens, California, United States | — |
| Site US10132 Axis Clinical Trials | Los Angeles, California, United States | — |
| Site US10133 Axis Clinical Trials | Los Angeles, California, United States | — |
| Site US10536 Stanford School of Medicine | Palo Alto, California, United States | — |
| Site US10149 Bayview Research Group | Paramount, California, United States | — |
+ 423 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01972841